🇺🇸 Fluarix Tetra in United States
22 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 22
Most-reported reactions
- Anaphylactic Reaction — 3 reports (13.64%)
- Covid-19 — 3 reports (13.64%)
- Abdominal Distension — 2 reports (9.09%)
- Abdominal Pain — 2 reports (9.09%)
- Anogenital Warts — 2 reports (9.09%)
- Dyspnoea — 2 reports (9.09%)
- Exposure During Pregnancy — 2 reports (9.09%)
- Hypertension — 2 reports (9.09%)
- Hypotension — 2 reports (9.09%)
- Influenza — 2 reports (9.09%)
Other Immunology approved in United States
Frequently asked questions
Is Fluarix Tetra approved in United States?
Fluarix Tetra does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Fluarix Tetra in United States?
University of Surrey is the originator. The local marketing authorisation holder may differ — check the official source linked above.